{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "AUTL",
        "Security_Name": "Autolus Therapeutics plc - American Depositary Shares",
        "Listing_Exchange": "Q",
        "Market_Category": "Q",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "AUTL",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 2,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 0,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 2,
                "buy": 0,
                "hold": 0,
                "sell": 0,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 1.845,
        "open": 1.85,
        "dayLow": 1.782,
        "dayHigh": 1.96,
        "regularMarketPreviousClose": 1.845,
        "regularMarketOpen": 1.85,
        "regularMarketDayLow": 1.782,
        "regularMarketDayHigh": 1.96,
        "payoutRatio": 0,
        "beta": 1.414262,
        "forwardPE": -0.9729729,
        "volume": 970447,
        "regularMarketVolume": 970447,
        "averageVolume": 531375,
        "averageVolume10days": 474110,
        "averageDailyVolume10Day": 474110,
        "bid": 1.78,
        "ask": 1.97,
        "bidSize": 1800,
        "askSize": 800,
        "marketCap": 131254200,
        "fiftyTwoWeekLow": 1.6,
        "fiftyTwoWeekHigh": 5.04,
        "priceToSalesTrailing12Months": 225.52267,
        "fiftyDayAverage": 2.2965,
        "twoHundredDayAverage": 2.873475,
        "currency": "USD",
        "fromCurrency": null,
        "lastMarket": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "3Q2020",
                    "actual": -0.72,
                    "estimate": -0.71
                },
                {
                    "date": "4Q2020",
                    "actual": -0.83,
                    "estimate": -0.77
                },
                {
                    "date": "1Q2021",
                    "actual": -0.53,
                    "estimate": -0.6
                },
                {
                    "date": "2Q2021",
                    "actual": -0.47,
                    "estimate": -0.5
                }
            ],
            "currentQuarterEstimate": -0.51,
            "currentQuarterEstimateDate": "3Q",
            "currentQuarterEstimateYear": 2021,
            "earningsDate": [
                1667433600
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 1472000,
                    "earnings": -57875000
                },
                {
                    "date": 2019,
                    "revenue": 2908000,
                    "earnings": -123849000
                },
                {
                    "date": 2020,
                    "revenue": 1715000,
                    "earnings": -142094000
                },
                {
                    "date": 2021,
                    "revenue": 2330000,
                    "earnings": -142096000
                }
            ],
            "quarterly": [
                {
                    "date": "3Q2021",
                    "revenue": 236000,
                    "earnings": -33991000
                },
                {
                    "date": "4Q2021",
                    "revenue": 180000,
                    "earnings": -41666000
                },
                {
                    "date": "1Q2022",
                    "revenue": 166000,
                    "earnings": -37062000
                },
                {
                    "date": "2Q2022",
                    "revenue": 0,
                    "earnings": -42059000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1667433600
            ],
            "earningsAverage": -0.51,
            "earningsLow": -0.56,
            "earningsHigh": -0.45,
            "revenueAverage": 250000,
            "revenueHigh": 640000
        }
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-08-05T00:00:00.000Z",
                "firm": "Needham",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2022-06-14T00:00:00.000Z",
                "firm": "Truist Securities",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-05-06T00:00:00.000Z",
                "firm": "Needham",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2021-03-10T00:00:00.000Z",
                "firm": "Redburn Partners",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2021-01-29T00:00:00.000Z",
                "firm": "JP Morgan",
                "toGrade": "Neutral",
                "fromGrade": "Overweight",
                "action": "down"
            },
            {
                "epochGradeDate": "2021-01-07T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-11-25T00:00:00.000Z",
                "firm": "Redburn Partners",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-07-31T00:00:00.000Z",
                "firm": "JP Morgan",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-07-22T00:00:00.000Z",
                "firm": "SunTrust Robinson Humphrey",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2020-06-19T00:00:00.000Z",
                "firm": "Mizuho",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-04-22T00:00:00.000Z",
                "firm": "Mizuho",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-09-23T00:00:00.000Z",
                "firm": "Needham",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-10-24T00:00:00.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-07-27T00:00:00.000Z",
                "firm": "Goldman Sachs",
                "toGrade": "Neutral",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-07-17T00:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-07-17T00:00:00.000Z",
                "firm": "Wells Fargo",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-07-17T00:00:00.000Z",
                "firm": "William Blair",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "DELAYED",
        "postMarketChangePercent": -0.0055555506,
        "postMarketChange": -0.00999999,
        "postMarketTime": "2023-01-06T21:58:44.000Z",
        "postMarketPrice": 1.79,
        "postMarketSource": "DELAYED",
        "regularMarketChangePercent": -0.024390286,
        "regularMarketChange": -0.045000076,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 4,
        "regularMarketPrice": 1.8,
        "regularMarketDayHigh": 1.96,
        "regularMarketDayLow": 1.782,
        "regularMarketVolume": 970447,
        "averageDailyVolume10Day": 474110,
        "averageDailyVolume3Month": 531375,
        "regularMarketPreviousClose": 1.845,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 1.85,
        "exchange": "NMS",
        "exchangeName": "NasdaqGS",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "AUTL",
        "underlyingSymbol": null,
        "shortName": "Autolus Therapeutics plc",
        "longName": "Autolus Therapeutics plc",
        "currency": "USD",
        "quoteSourceName": "Delayed Quote",
        "currencySymbol": "$",
        "fromCurrency": null,
        "lastMarket": null,
        "marketCap": 131254200
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": 75313544,
        "forwardPE": -0.9473684,
        "profitMargins": 0,
        "floatShares": 26464747,
        "sharesOutstanding": 72919000,
        "sharesShort": 1002888,
        "sharesShortPriorMonth": 1080681,
        "sharesShortPreviousMonthDate": 1663200000,
        "dateShortInterest": 1665705600,
        "sharesPercentSharesOut": 0.011,
        "heldPercentInsiders": 0.16083999,
        "heldPercentInstitutions": 0.55935,
        "shortRatio": 4.96,
        "beta": 1.414262,
        "category": null,
        "bookValue": 5.91,
        "priceToBook": 0.30456853,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-06-30T00:00:00.000Z",
        "netIncomeToCommon": -154776000,
        "trailingEps": -1.4,
        "forwardEps": -1.85,
        "lastSplitFactor": null,
        "enterpriseToRevenue": 129.405,
        "enterpriseToEbitda": -0.45
    },
    "summaryProfile": {
        "address1": "The MediaWorks",
        "address2": "191 Wood Lane White City",
        "city": "London",
        "zip": "W12 7FP",
        "country": "United Kingdom",
        "phone": "44 20 3829 6230",
        "website": "https://www.autolus.com",
        "industry": "Biotechnology",
        "sector": "Healthcare",
        "longBusinessSummary": "Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma. It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.",
        "fullTimeEmployees": 324,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 1.8,
        "targetHighPrice": 28,
        "targetLowPrice": 5.5,
        "targetMeanPrice": 15.06,
        "targetMedianPrice": 13,
        "recommendationMean": 2,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 9,
        "totalCash": 216436992,
        "totalCashPerShare": 2.381,
        "ebitda": -167218000,
        "totalDebt": 17203000,
        "quickRatio": 7.128,
        "currentRatio": 7.291,
        "totalRevenue": 582000,
        "debtToEquity": 8.019,
        "revenuePerShare": 0.007,
        "returnOnAssets": -0.34063,
        "returnOnEquity": -0.62134,
        "grossProfits": -132459000,
        "freeCashflow": -80600248,
        "operatingCashflow": -109745000,
        "grossMargins": 0,
        "ebitdaMargins": 0,
        "operatingMargins": -301.83163,
        "profitMargins": 0,
        "financialCurrency": "USD"
    }
}